ARIKAYCE

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, United Kingdom, United States

Active ingredients

The drug ARIKAYCE contains one active pharmaceutical ingredient (API):

1 Amikacin UNII 84319SGC3C - AMIKACIN

Amikacin is an antibiotic used for a number of bacterial infections. Amikacin works by blocking the function of the bacteria’s 30S ribosomal subunit, making it unable to produce proteins. Read about Amikacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ARIKAYCE Inhalation suspension	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01GB06	Amikacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01G Aminoglycoside antibacterials → J01GB Other aminoglycosides
Discover more medicines within J01GB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1831429
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 191886
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 395830
Country: JP	医薬品医療機器総合機構	Identifier(s): 6169700G1025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091321
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 206237
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100446218
Country: US	FDA, National Drug Code	Identifier(s): 71558-590